Rapid Microbiology Testing Market by Product (Reagents, Kits, Automated Identification System, PCR, Mass Spectrometry), Method (Growth, Nucleic Acid, Viability), Applications (Clinical Diagnosis, Pharma, Environmental) - Global Forecast to 2026
Updated on : April 14, 2023
The global rapid microbiology testing market in terms of revenue was estimated to be worth $4.2 billion in 2021 and is poised to reach $6.7 billion by 2026, growing at a CAGR of 9.4% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Market growth is driven by the growing incidence of epidemics, increased infectious diseases and Increasing incidence of cancer.
To know about the assumptions considered for the study, Request for Free Sample Report
Rapid Microbiology Testing Market Dynamics
Driver: Increasing incidence of infectious disease and growing outbreaks of epidemics.
There is an increase in incidence of infectious diseases and other epidemics and pandemics like Pneumonia and COVID-19 which has increased the use of diagnostic tests. With a rise in the global burden of these diseases, there is increased awareness amongst the public for early diseases detection which is the reason for significant growth during the forecast period
Opportunity: Growth opportunities in emerging countries
Emerging economies such as India, South Korea, Brazil, and Mexico offer significant growth opportunities to players operating in the market. This can be attributed to the high disease prevalence, large patient population, improving healthcare infrastructure, increasing disposable income, and growing medical tourism in these countries.
Restraint: High capital investments and low cost-benefit ratio.
Development of diagnostic tests specifically for cancer and infectious diseases requires high capital investment. Specifically to meet theregulatory requirements. Increased regulatory guidelines for each clinical trial phase interrupts the process of development leading to the need of heavy investments for clinical trials and approval. Hence, along with the high amount of capital investments, the low cost-benefit ratio is hindering the growth of the market.
Challenge: Improving healthcare infrastructure
Growing healthcare expenditure, and increasing availability and affordability of low-cost clinical microbiology products. Emerging countries are witnessing rapid modernization in healthcare facilities and expansion of healthcare infrastructure. Small emerging companies are collaborating to develop new and improved products.
Instruments segment accounted for the largest share of the rapid microbiology testing market
Development and extensive use of advanced molecular diagnostic techniques such as NGS, real-time PCR, molecular cartridges, and PCR coupled with mass spectrometry. development and commercialization of pathogen-specific reagent/diagnostic kits have led to better sample utilization will drive the market growth.
Growth-based rapid microbiology testing segment accounted for the largest share in the rapid microbiology testing market
Growing R&D investments to develop new rapid diagnostic kits, increased adoption of rapid POC diagnostic tests to diagnose diseases like COVID-19 are the drivers that attribute to the growth of the market.
Clinical disease diagnosis segment accounted for the largest share in the rapid microbiology testing market
Rising geriatric population, and subsequent growth of infectious diseases is expected to increase the prevalence of various diseases across the globe, decreased public immune system, new developments in the diagnostic market are the factors that will support the market growth.
North America is the largest regional market for rapid microbiology testing market
The global market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global market. The North American market growth can be attributed to the, increased government initiatives for healthcare development, increased awareness on the early detection of infectious disease and increased incidence of infectious disease and cancer.
To know about the assumptions considered for the study, download the pdf brochure
Key players operating in the global rapid microbiology testing market are
- Biomérieux SA (France)
- Danaher Corporation (US)
- Becton, Dickinson and Company (US)
- Abbott Laboratories, Inc. (US)
- Thermo Fisher Scientific (US)
Scope of the Rapid Microbiology Testing Market Report
|
Report Metrics |
Details |
|
Market Size value 2026 |
USD 6.7 billion |
|
Growth Rate |
9.4% CAGR |
|
Largest Market |
North America |
|
Market Dynamics |
Drivers, Opportunities, Restraints & Challenges |
|
Largest Share Segments |
Instruments, Growth-based rapid microbiology testing & Clinical disease diagnosis |
|
Forecasts up to |
2026 |
|
Market Segmentation |
Product, Method, Applications and Region |
|
Growth Drivers |
|
|
Growth Opportunities |
|
|
Geographies covered |
North America, Europe, APAC, MEA, and Latin America |
This report categorizes the rapid microbiology testing market into the following segments and sub-segments:
By Product
-
Instruments
- Automated Microbial Identification & Antimicrobial Susceptibility Testing System
- Mass Spectrometers
- Bioluminescence & Fluorescence-Based Detection System
- PCR Systems
- Cytometers
- Active Air Samplers
- Other Instruments
-
Reagents and Kits
- Sterility Reagents and Kits
- Other Reagents and Kits
- Consumables
By Method
- Growth-Based Rapid Microbiology Testing
- Cellular component-Based Rapid Microbiology Testing
- Nucleic Acid-Based Rapid Microbiology Testing
- Viability-Based Rapid Microbiology Testing
By Applications
- Clinical Disease Diagnostics
- Food & Beverage testing
- Pharmaceutical & Biological Drug Testing
- Environmental Testing
- Cosmetics and Personal Care Products Testing
- Research Applications
- Other Applications
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Rest of Europe
-
Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments
- In October 2020, Merck KGAA (Germany) collaborated with Mammoth Biosciences (US) for the development, scale up and commercial production of CRISPR- based SARS-COV-2 diagnostic test.
- In September 2020, Bruker Corporation (US) has an acquisition with Canopy Bioscience LLC ( US) which enhanced bruker’s offerings in targeted multi-omics and fluorescence-based imaging technique.
- In July 2020, Biomérieux SA (France) launched Biofire mycoplasma test for the detection of mycoplasma in biopharmaceutical products.
Frequently Asked Questions (FAQ):
What is the projected market value of the global rapid microbiology testing market?
The global rapid microbiology testing market boasts a total revenue value of $4.2 billion in 2021 and is projected to register a revenue value of $6.7 billion by 2026.
What is the estimated growth rate (CAGR) of the global rapid microbiology testing market for the next five years?
The global rapid microbiology testing market in terms of revenue is poised to grow at a CAGR of 9.4%.
What does the current study of the rapid microbiology testing market consist of?
The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 36)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
FIGURE 1 RAPID MICROBIOLOGY TESTING MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 42)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 2 RAPID MICROBIOLOGY TESTING MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
FIGURE 4 MARKET: BOTTOM-UP APPROACH
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 6 MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
2.6 GROWTH RATE ASSUMPTIONS
2.7 LIMITATIONS
2.8 RISK ASSESSMENT
2.9 COVID-19 HEALTH ASSESSMENT
2.10 COVID-19 ECONOMIC ASSESSMENT
2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.12 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE MARKET
3 EXECUTIVE SUMMARY (Page No. - 56)
FIGURE 10 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 11 MARKET, BY METHOD, 2021 VS. 2026 (USD MILLION)
FIGURE 12 MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 13 MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 60)
4.1 RAPID MICROBIOLOGY TESTING MARKET OVERVIEW
FIGURE 14 RISING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
4.2 MARKET SHARE, BY PRODUCT, 2021 VS. 2026
FIGURE 15 INSTRUMENTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.3 MARKET SHARE, BY METHOD, 2021 VS. 2026
FIGURE 16 GROWTH-BASED RAPID MICROBIOLOGY TESTING SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.4 MARKET SHARE, BY APPLICATION, 2021 VS. 2026
FIGURE 17 CLINICAL DISEASE DIAGNOSIS IS THE LARGEST APPLICATION SEGMENT OF RAPID MICROBIOLOGY TESTS
4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 64)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 RAPID MICROBIOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing incidence of infectious diseases and cancer
5.2.1.2 Technological advancements in rapid microbiology testing
5.2.1.3 Increased funding for R&D
5.2.1.4 Increased focus on the early detection of infectious diseases
5.2.2 RESTRAINTS
5.2.2.1 High capital investments and low cost-benefit ratio
5.2.2.2 Unfavorable regulatory and reimbursement scenarios
5.2.3 OPPORTUNITIES
5.2.3.1 Growth opportunities in emerging countries
5.2.4 CHALLENGES
5.2.4.1 Operational barriers
5.3 IMPACT OF COVID-19 ON THE MARKET
5.3.1 GLOBAL TREND IN THE SARS-COV-2 RAPID DIAGNOSTICS MARKET
5.4 PRICING ANALYSIS
TABLE 1 PRICES OF RAPID MICROBIOLOGY TESTS (2021)
5.5 PATENT ANALYSIS
5.6 TRADE ANALYSIS
5.6.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 2 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 3 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016–2020 (USD MILLION)
5.7 VALUE CHAIN ANALYSIS
FIGURE 20 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 21 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.9 ECOSYSTEM ANALYSIS OF THE MARKET
FIGURE 22 MARKET: ECOSYSTEM ANALYSIS
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF BUYERS
5.10.4 BARGAINING POWER OF SUPPLIERS
5.10.5 DEGREE OF COMPETITION
5.11 PESTLE ANALYSIS
5.12 REGULATORY LANDSCAPE
5.12.1 NORTH AMERICA
5.12.1.1 US
5.12.1.2 Canada
5.12.2 EUROPE
5.12.3 ASIA PACIFIC
5.12.3.1 Japan
5.12.3.2 India
5.12.3.3 China
5.12.4 LATIN AMERICA
5.12.4.1 Brazil
5.12.4.2 Mexico
5.12.5 MIDDLE EAST
5.12.6 AFRICA
5.13 TECHNOLOGY ANALYSIS
5.14 DISRUPTIVE TECHNOLOGIES IN THE MARKET
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR THE MARKET
FIGURE 23 REVENUE SHIFT FOR THE MARKET
6 RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT (Page No. - 81)
6.1 INTRODUCTION
TABLE 5 MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 6 MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
6.2 INSTRUMENTS
TABLE 7 KEY PRODUCTS IN THE RAPID MICROBIOLOGY INSTRUMENTS MARKET
TABLE 8 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 9 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 10 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 11 RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY REGION, 2020–2026 (USD MILLION)
6.2.1 AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS
6.2.1.1 Ease of use as compared to conventional identification processes is the major factor supporting the growth of this segment
TABLE 12 MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY REGION, 2016–2019 (USD MILLION)
TABLE 13 MARKET FOR AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS, BY REGION, 2020–2026 (USD MILLION)
6.2.2 MASS SPECTROMETERS
6.2.2.1 Mass spectrometry methods provide rapid results for microbial identification within a few minutes
TABLE 14 MARKET FOR MASS SPECTROMETERS, BY REGION, 2016–2019 (USD MILLION)
TABLE 15 MARKET FOR MASS SPECTROMETERS, BY REGION, 2020–2026 (USD MILLION)
6.2.3 BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS
6.2.3.1 Unwanted detection of non-microbial ATP is one of the major disadvantages associated with this technique
TABLE 16 MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY REGION, 2016–2019 (USD MILLION)
TABLE 17 MARKET FOR BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEMS, BY REGION, 2020–2026 (USD MILLION)
6.2.4 PCR SYSTEMS
6.2.4.1 Standard PCR, real-time PCR, and qPCR are the common PCR techniques used for rapid microbial testing
TABLE 18 MARKET FOR PCR SYSTEMS, BY REGION, 2016–2019 (USD MILLION)
TABLE 19 MARKET FOR PCR SYSTEMS, BY REGION, 2020–2026 (USD MILLION)
6.2.5 CYTOMETERS
6.2.5.1 Ability to detect viable organisms to support market growth
TABLE 20 MARKET FOR CYTOMETERS, BY REGION, 2016–2019 (USD MILLION)
TABLE 21 MARKET FOR CYTOMETERS, BY REGION, 2020–2026 (USD MILLION)
6.2.6 ACTIVE AIR SAMPLERS
6.2.6.1 Rapid active air samplers are convenient and easy to use and offer more sensitive and complete results in real-time
TABLE 22 MARKET FOR ACTIVE AIR SAMPLERS, BY REGION, 2016–2019 (USD MILLION)
TABLE 23 MARKET FOR ACTIVE AIR SAMPLERS, BY REGION, 2020–2026 (USD MILLION)
6.2.7 OTHER INSTRUMENTS
TABLE 24 MARKET FOR OTHER INSTRUMENTS, BY REGION, 2016–2019 (USD MILLION)
TABLE 25 MARKET FOR OTHER INSTRUMENTS, BY REGION, 2020–2026 (USD MILLION)
6.3 REAGENTS & KITS
TABLE 26 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 27 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 28 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 29 RAPID MICROBIOLOGY TESTING REAGENTS & KITS MARKET, BY REGION, 2020–2026 (USD MILLION)
6.3.1 STERILITY REAGENTS & KITS
6.3.1.1 Increasing adoption of BET assays to propel market growth
TABLE 30 MARKET FOR STERILITY TESTING REAGENTS & KITS, BY REGION, 2016–2019 (USD MILLION)
TABLE 31 MARKET FOR STERILITY TESTING REAGENTS & KITS, BY REGION, 2020–2026 (USD MILLION)
6.3.2 OTHER REAGENTS & KITS
TABLE 32 MARKET FOR OTHER REAGENTS & KITS, BY REGION, 2016–2019 (USD MILLION)
TABLE 33 MARKET FOR OTHER REAGENTS & KITS, BY REGION, 2020–2026 (USD MILLION)
6.4 CONSUMABLES
6.4.1 DEVELOPMENT OF AUTOMATED ZONE READERS AND DISPENSERS TO DRIVE MARKET GROWTH
TABLE 34 RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 35 RAPID MICROBIOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2020–2026 (USD MILLION)
7 RAPID MICROBIOLOGY TESTING MARKET, BY METHOD (Page No. - 102)
7.1 INTRODUCTION
TABLE 36 MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 37 MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 38 TYPES OF TECHNOLOGIES USED IN VARIOUS RAPID MICROBIOLOGY TESTING METHODS
7.2 GROWTH-BASED RAPID MICROBIOLOGY TESTING
7.2.1 GROWTH-BASED RAPID MICROBIOLOGY TESTING IS THE LARGEST METHOD SEGMENT
TABLE 39 MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 40 MARKET, BY REGION, 2020–2026 (USD MILLION)
7.3 CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING
7.3.1 THIS METHOD OFFERS A HIGH LEVEL OF SENSITIVITY, ACCURACY, AND SPECIFICITY
TABLE 41 MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 42 MARKET, BY REGION, 2020–2026 (USD MILLION)
7.4 NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING
7.4.1 NUCLEIC ACID-BASED METHODS TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
TABLE 43 MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 44 MARKET, BY REGION, 2020–2026 (USD MILLION)
7.5 VIABILITY-BASED RAPID MICROBIOLOGY TESTING
7.5.1 NEAR REAL-TIME DETECTION AND IMPROVED ACCURACY ARE SOME OF THE ADVANTAGES DRIVING THE ADOPTION OF THIS SEGMENT
TABLE 45 MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 46 MARKET, BY REGION, 2020–2026 (USD MILLION)
7.6 OTHER RAPID MICROBIOLOGY TESTING METHODS
TABLE 47 OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 48 OTHER RAPID MICROBIOLOGY TESTING METHODS MARKET, BY REGION, 2020–2026 (USD MILLION)
8 RAPID MICROBIOLOGY TESTING MARKET, BY APPLICATION (Page No. - 112)
8.1 INTRODUCTION
TABLE 49 MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 50 MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
8.2 CLINICAL DISEASE DIAGNOSIS
8.2.1 HIGH BURDEN OF INFECTIOUS DISEASES AND HAIS TO PROPEL MARKET GROWTH
TABLE 51 MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY REGION, 2016–2019 (USD MILLION)
TABLE 52 MARKET FOR CLINICAL DISEASE DIAGNOSIS, BY REGION, 2020–2026 (USD MILLION)
8.3 FOOD & BEVERAGE TESTING
8.3.1 FOOD & BEVERAGE TESTING IS THE FASTEST-GROWING APPLICATION SEGMENT IN THE MARKET
TABLE 53 MARKET FOR FOOD & BEVERAGE TESTING, BY REGION, 2016–2019 (USD MILLION)
TABLE 54 MARKET FOR FOOD & BEVERAGE TESTING, BY REGION, 2020–2026 (USD MILLION)
8.4 PHARMACEUTICAL & BIOLOGICAL DRUG TESTING
8.4.1 IMPROVED REGULATORY SCENARIO FOR DRUG DEVELOPMENT TO SUPPORT MARKET GROWTH
TABLE 55 MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY REGION, 2016–2019 (USD MILLION)
TABLE 56 MARKET FOR PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY REGION, 2020–2026 (USD MILLION)
8.5 ENVIRONMENTAL TESTING
8.5.1 GROWING FOCUS ON ENVIRONMENTAL MONITORING WILL BOOST THE GROWTH OF THIS SEGMENT
TABLE 57 MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2016–2019 (USD MILLION)
TABLE 58 MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2020–2026 (USD MILLION)
8.6 COSMETICS & PERSONAL CARE PRODUCTS TESTING
8.6.1 RAPID MICROBIOLOGY TESTING IS WIDELY USED IN THESE INDUSTRIES TO DETERMINE THE PRESENCE OF MICROBES IN THE MANUFACTURING PROCESS
TABLE 59 MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING, BY REGION, 2016–2019 (USD MILLION)
TABLE 60 MARKET FOR COSMETICS & PERSONAL CARE PRODUCTS TESTING, BY REGION, 2020–2026 (USD MILLION)
8.7 RESEARCH APPLICATIONS
8.7.1 INCREASING USE OF MICROBIOLOGY TESTING SERVICES BY ACADEMIC & RESEARCH INSTITUTES TO DRIVE MARKET GROWTH
TABLE 61 MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
TABLE 62 MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2026 (USD MILLION)
8.8 OTHER APPLICATIONS
TABLE 63 MARKET FOR OTHER APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
TABLE 64 MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2026 (USD MILLION)
9 RAPID MICROBIOLOGY TESTING MARKET, BY REGION (Page No. - 126)
9.1 INTRODUCTION
TABLE 65 MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 66 MARKET, BY REGION, 2020–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 24 NORTH AMERICA: MARKET SNAPSHOT
TABLE 67 NORTH AMERICA: MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 68 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 69 NORTH AMERICA: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 70 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 71 NORTH AMERICA: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 72 NORTH AMERICA: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 73 NORTH AMERICA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 74 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.2.1 US
9.2.1.1 Adoption of technologically advanced products in the US to favor market growth
TABLE 75 US: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 76 US: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 77 US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 78 US: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 79 US: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 80 US: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 81 US: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 82 US: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Favorable environment for R&D and rising incidence of infectious diseases to drive the market in Canada
TABLE 83 CANADA: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 84 CANADA: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 85 CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 86 CANADA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 87 CANADA: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 88 CANADA: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 89 CANADA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 90 CANADA: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.3 EUROPE
TABLE 91 EUROPE: RAPID MICROBIOLOGY TESTING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 92 EUROPE: MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 93 EUROPE: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 94 EUROPE: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 95 EUROPE: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 96 EUROPE: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 97 EUROPE: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 98 EUROPE: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany is the largest & fastest-growing market for rapid microbiology testing in Europe
TABLE 99 GERMANY: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 100 GERMANY: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 101 GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 102 GERMANY: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 103 GERMANY: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 104 GERMANY: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 105 GERMANY: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 106 GERMANY: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Rising R&D expenditure to drive market growth
TABLE 107 FRANCE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 108 FRANCE: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 109 FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 110 FRANCE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 111 FRANCE: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 112 FRANCE: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 113 FRANCE: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 114 FRANCE: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.3.3 UK
9.3.3.1 Increasing investments and funding by the government to drive the market growth in the UK
TABLE 115 UK: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 116 UK: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 117 UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 118 UK: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 119 UK: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 120 UK: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 121 UK: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 122 UK: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.3.4 REST OF EUROPE
TABLE 123 ROE: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 124 ROE: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 125 ROE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 126 ROE: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 127 ROE: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 128 ROE: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 129 ROE: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 130 ROE: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 25 ASIA PACIFIC: MARKET SNAPSHOT
TABLE 131 ASIA PACIFIC: MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 132 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
TABLE 133 ASIA PACIFIC: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 134 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 135 ASIA PACIFIC: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 136 ASIA PACIFIC: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 137 ASIA PACIFIC: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 138 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Increasing funding for R&D to drive market growth
TABLE 139 CHINA: KEY MACROINDICATORS
TABLE 140 CHINA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 141 CHINA: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 142 CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 143 CHINA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 144 CHINA: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 145 CHINA: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 146 CHINA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 147 CHINA: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising geriatric population in Japan to support market growth
TABLE 148 JAPAN: KEY MACROINDICATORS
TABLE 149 JAPAN: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 150 JAPAN: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 151 JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 152 JAPAN: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 153 JAPAN: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 154 JAPAN: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 155 JAPAN: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 156 JAPAN: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 High incidence of infectious diseases in the country to drive the adoption of rapid microbiology testing products
TABLE 157 INDIA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 158 INDIA: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 159 INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 160 INDIA: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 161 INDIA: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 162 INDIA: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 163 INDIA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 164 INDIA: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 165 ROAPAC: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 166 ROAPAC: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 167 ROAPAC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 168 ROAPAC: RAPID MICROBIOLOGY TESTING INSTRUMENTS MARKET, BY TYPE, 2020–2026 (USD MILLION)
TABLE 169 ROAPAC: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 170 ROAPAC: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 171 ROAPAC: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 172 ROAPAC: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 INCREASING PER CAPITA HEALTHCARE EXPENDITURE TO SUPPORT MARKET GROWTH
TABLE 173 LATIN AMERICA: RAPID MICROBIOLOGY TESTING MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 174 LATIN AMERICA: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 175 LATIN AMERICA: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 176 LATIN AMERICA: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 177 LATIN AMERICA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 178 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH
TABLE 179 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT, 2016–2019 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: MARKET, BY METHOD, 2016–2019 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: MARKET, BY METHOD, 2020–2026 (USD MILLION)
TABLE 183 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 184 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 194)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE RAPID MICROBIOLOGY TESTING MARKET
TABLE 185 OVERVIEW OF STRATEGIES DEPLOYED BY KEY RAPID MICROBIOLOGY TESTING MANUFACTURING COMPANIES
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 27 MARKET SHARE, BY KEY PLAYER (2020)
TABLE 186 MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION QUADRANT
10.5.1 LIST OF EVALUATED VENDORS
10.5.2 STARS
10.5.3 EMERGING LEADERS
10.5.4 PERVASIVE PLAYERS
10.5.5 PARTICIPANTS
FIGURE 28 MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 29 MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020
10.7 COMPETITIVE BENCHMARKING
FIGURE 30 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE RAPID MICROBIOLOGY TESTING MARKET
TABLE 187 COMPANY PRODUCT FOOTPRINT
TABLE 188 COMPANY GEOGRAPHICAL FOOTPRINT
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES & REGULATORY APPROVALS
TABLE 189 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
10.8.2 DEALS
TABLE 190 KEY DEALS
11 COMPANY PROFILES (Page No. - 206)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 BIOMÉRIEUX SA
TABLE 191 BIOMÉRIEUX: BUSINESS OVERVIEW
FIGURE 31 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2020)
11.1.2 DANAHER CORPORATION
TABLE 192 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.3 BECTON, DICKINSON AND COMPANY
TABLE 193 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
11.1.4 ABBOTT LABORATORIES
TABLE 194 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 34 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
11.1.5 THERMO FISHER SCIENTIFIC INC.
TABLE 195 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 35 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
11.1.6 MERCK KGAA
TABLE 196 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2020)
11.1.7 SARTORIUS AG
TABLE 197 SARTORIUS AG: BUSINESS OVERVIEW
FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT (2020)
11.1.8 BRUKER CORPORATION
TABLE 198 BRUKER CORPORATION: BUSINESS OVERVIEW
FIGURE 38 BRUKER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.9 QUIDEL CORPORATION
TABLE 199 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 39 QUIDEL CORPORATION: COMPANY SNAPSHOT (2020)
11.1.10 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
TABLE 200 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW
FIGURE 40 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2020)
11.1.11 NEOGEN CORPORATION
TABLE 201 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 41 NEOGEN CORPORATION: COMPANY SNAPSHOT (2020)
11.2 OTHER PLAYERS
11.2.1 DON WHITLEY SCIENTIFIC
TABLE 202 DON WHITLEY SCIENTIFIC: BUSINESS OVERVIEW
11.2.2 RAPID MICRO BIOSYSTEMS
TABLE 203 RAPID MICRO BIOSYSTEMS: BUSINESS OVERVIEW
11.2.3 VIVIONE BIOSCIENCES, LLC
TABLE 204 VIVIONE BIOSCIENCES, LLC: BUSINESS OVERVIEW
11.2.4 GRADIENTECH
TABLE 205 GRADIENTECH: BUSINESS OVERVIEW
11.2.5 RQMICRO AG
TABLE 206 RQMICRO AG: BUSINESS OVERVIEW
11.2.6 BACTEST LTD.
TABLE 207 BACTEST LTD.: BUSINESS OVERVIEW
11.2.7 COLIFAST
TABLE 208 COLIFAST: BUSINESS OVERVIEW
11.2.8 SEROSEP LTD.
TABLE 209 SEROSEP LTD.: BUSINESS OVERVIEW
11.2.9 BIOSENSIA LTD.
TABLE 210 BIOSENSIA LTD.: BUSINESS OVERVIEW
11.2.10 SOLUS SCIENTIFIC SOLUTIONS LTD.
TABLE 211 SOLUS SCIENTIFIC SOLUTIONS LTD.: BUSINESS OVERVIEW
11.2.11 LUBIOSCIENCE GMBH
TABLE 212 LUBIOSCIENCE GMBH: BUSINESS OVERVIEW
11.2.12 EUROCLONE SPA
TABLE 213 EUROCLONE SPA: BUSINESS OVERVIEW
11.2.13 CORDX
TABLE 214 CORDX: BUSINESS OVERVIEW
11.2.14 R-BIOPHARM AG
TABLE 215 R-BIOPHARM AG: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 269)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the rapid microbiology testing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the rapid microbiology testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the electroceuticals market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Market Size: Top-Down Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, segment, and forecast the rapid microbiology testing market by product, method, application and region.
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2.
- To track and analyze company developments such as product launches, agreements, expansions, and acquisitions in the rapid microbiology testing market.
- To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Country Information
Rapid Microbiology Testing market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa
Company profiles
Additional five company profiles of players operating in the electroceuticals market
Generating Response ...
Growth opportunities and latent adjacency in Rapid Microbiology Testing Market